Medtronic plc
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B | $4.63B |
| Depreciation & Amortization | $2.96B | $2.86B | $2.65B | $2.70B | $2.71B | $2.70B | $2.66B | $2.66B |
| Depreciation | $1.19B | $1.05B | $954.0M | $999.0M | $974.0M | $919.0M | $907.0M | $895.0M |
| Amortization | $1.77B | $1.81B | $1.69B | $1.70B | $1.73B | $1.78B | $1.76B | $1.76B |
| Stock-Based Compensation | $457.0M | $429.0M | $393.0M | $355.0M | $359.0M | $344.0M | $297.0M | $290.0M |
| Net Cash from Operating Activities | $7.33B | $7.04B | $6.79B | $6.04B | $7.35B | $6.24B | $7.23B | $7.01B |
| Investing Activities | ||||||||
| Capital Expenditures | $1.90B | $1.86B | $1.59B | $1.46B | $1.37B | $1.36B | $1.21B | $1.13B |
| Business Acquisitions | $406.0M | $98.0M | $211.0M | $1.87B | $91.0M | $994.0M | $488.0M | $1.83B |
| Net Cash from Investing Activities | $-2.93B | $-1.94B | $-2.37B | $-3.49B | $-1.66B | $-2.87B | $-3.20B | $-774.0M |
| Financing Activities | ||||||||
| Dividends Paid | $3.64B | $3.59B | $3.67B | $3.62B | $3.38B | $3.12B | $2.89B | $2.69B |
| Stock Repurchases | $1.04B | $3.24B | $2.14B | $645.0M | $2.54B | $652.0M | $1.33B | $2.88B |
| Net Cash from Financing Activities | $-4.75B | $-4.36B | $-4.45B | $-4.96B | $-5.34B | $-4.14B | $-4.20B | $-5.43B |
| Net Change in Cash | $-269.0M | $934.0M | $-259.0M | $-2.17B | $121.0M | $-547.0M | $-253.0M | $724.0M |
| Free Cash Flow | $5.43B | $5.19B | $5.20B | $4.58B | $5.98B | $4.89B | $6.02B | $5.87B |